AnPac Bio-Medical Science
AnPac Bio-Medical Science is a biotechnology company focusing on pre-cancer and cancer screening to develop early disease detection devices that are more accessible. AnPaC Bio aims to develop, distribute, and deploy this technology to change the way people think about screening.
We’re harnessing Cancer Differentiation Analysis technology to detect cancer risk and disease earlier. Through development of the CDA device which performs several biophysical tests with a standard blood sample, and our proprietary algorithm, it uses this biophysical data to generate a pre-cancer disease and cancer risk assessment from each sample.
AnPac Bio is defined by our passionate team of scientists and health technology leaders. Our success is built on the collaborations between scientists, engineers, and experienced professionals from multiple disciplines. Anpac Bio is looking for experienced, talented, and innovative researchers, scientists, technicians, and other biotech leaders, for the company’s U.S. division located in the Greater Philadelphia Area. We work together with creativity and integrity, driven by our culture of teamwork, social consciousness, and commitment to excellence. For more information regarding Anpac Bio employment, or to apply for open positions please contact: [email protected]
Anpac Bio provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.
We have our corporate headquarters in Shanghai, China, with U.S. headquarters in Philadelphia, PA. We have two clinical laboratories in the United States, and two in China.
It all started with a question: “What if we could detect cancer before tumors start?”
Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.Read the full article